Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mechanistic analysis on epigenetic programming of tumor drug resistance

Drug Resistance Updates(2026)10.1016/j.drup.2026.101441Source: DataRank Database

Mechanistic analysis on epigenetic programming of tumor drug resistance is a research paper published in Drug Resistance Updates (2026). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: closedTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Kun Pang,Jia-Hao Sun ORCID,Yu-Fei Lou,Zhen-Yuan Zhang,Jiang-Shang Bao

Live enrichment

PubMed:42418987 OpenAlex:https://openalex.org/W7166657297

Beijing Xisike Clinical Oncology Research Foundation

Grant: Y-Young2024\u20130036

Xuzhou Medical University

Grant: XYFC202404

Natural Science Foundation of Jiangsu Province

Grant: BK20251765

Jiangsu Commission of Health

Grant: K2023041

FWCI

0.00

Citation Percentile

0.7%

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S1368764626000920?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1368764626000920?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.drup.2026.101441

repositoryhttps://pubmed.ncbi.nlm.nih.gov/42418987

Fields of Study

Epigenetics and DNA MethylationCancer Cells and MetastasisChromatin Remodeling and CancerHumansDrug Resistance, NeoplasmEpigenesis, GeneticNeoplasmsAntineoplastic AgentsDNA MethylationGene Expression Regulation, NeoplasticRNA MethylationHistonesAnimalsRNA, Untranslated

MeSH Terms

RNA MethylationAnimalsAntineoplastic AgentsHistonesHumansNeoplasmsGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmDNA MethylationRNA, UntranslatedEpigenesis, Genetic

Keywords

EpigeneticsDrug resistanceDrugDNA methylationEpigenesisMechanism (biology)BiomarkersTherapeutic Targets

Sustainable Development Goals

SDG 0: Good health and well-being

Mechanistic analysis on epigenetic programming of tumor drug resistance

FAIR Checklist

Authors (11)

Funding (4 grants)

Impact

Open Access

Topics